Delving into the Latest Updates on CHX Technologies, Inc. with Synapse

Overview

Prevora is an antiseptic medication and dental treatment approved by Health Canada for reducing root decay (cavities) in adults at high risk of dental decay. An antiseptic kills germs and harmful bacteria. Prevora is applied to the teeth and gumline by a medical professional, takes about 10 minutes and is painless.
Participating site(s) have a homecare program and usual care includes offering patients home care services before discharge from the hospital for some chronic diseases. Usual care includes home visits by a nurse and or personal support worker (PSW).
The aim of this study is to explore the effectiveness, health benefits and feasibility of delivering preventive oral healthcare with Prevora, during a homecare visit by a nurse or PSW. All consenting and eligible subjects will continue with their usual care with the homecare program. The study is 5 months long. Subjects will have a Prevora treatment applied by the homecare nurse or PSW on Day 1, 14 days, 3 months and 4 months. The study includes several follow up visits which will be conducted in the patient's home and or by telephone or videoconferencing if needed. Oral exams, lab tests and subject completed questionnaires will be collected for the study. Changes in medications and any possible side effects will also be monitored during the study.

Start Date01 Dec 2023

Sponsor / Collaborator

CHX Technologies, Inc.

ISRCTN14373079

/ CompletedPhase 4

A study to survey the oral health status of Canadian seniors and to prevent poor oral health in Canadian seniors

Start Date15 Nov 2022

Sponsor / Collaborator

CHX Technologies, Inc.

EUCTR2006-006104-11-DE

/ Not yet recruitingNot Applicable

Phase IV Open-label Pharmaco-economic and Practice Management Study of a New Preventive Treatment for Adults Caries in the U.K. and Germany - PPMS

Start Date14 May 2007

Sponsor / Collaborator

CHX Technologies, Inc.

100 Clinical Results associated with CHX Technologies, Inc.

Login to view more data

0 Patents (Medical) associated with CHX Technologies, Inc.

Login to view more data

1

Literatures (Medical) associated with CHX Technologies, Inc.

01 Aug 2015·Journal of DentistryQ2 · MEDICINE

Factors affecting patient valuations of caries prevention: Using and validating the willingness to pay method

Q2 · MEDICINE

Article

Author: Steele, Jimmy G ; Whitworth, John M ; Walls, Angus W G ; Vernazza, Christopher R ; Hahn, Petra ; Perry, Ross ; Matthews, Roger ; Wildman, John R ; Donaldson, Cam

OBJECTIVESDetermining the value of, or strength of preference for health care interventions is useful for policy makers in planning health care services. Willingness to pay (WTP) is an established economic technique to determine the strength of preferences for interventions by eliciting monetary valuations from individuals in hypothetical situations. The objective of this study was to elicit WTP values for a dental preventive intervention and to analyze the factors affecting these as well as investigating the validity of the WTP method.METHODSPatients aged 40 years plus attending dental practices in the UK and Germany were recruited on a consecutive basis over one month. Participants received information about a novel root caries prevention intervention. They then completed a questionnaire including a WTP task. Where the coating was indicated, patients were offered this for a payment and acceptance was recorded. Analysis included econometric modelling and comparison of expected (based on stated WTP) versus actual behaviour.RESULTSThe mean WTP for the coating was £96.41 (standard deviation 60.61). Econometric models showed that no demographic or dental history factors were significant predictors of WTP. 63% of the sample behaved as expected when using stated WTP to predict whether they would buy the coating. The remainder were split almost equally between those expected to pay but who did not and those who were expected to refuse but paid.CONCLUSIONSValues for a caries preventive intervention had a large and unpredictable variance. In comparing hypothetical versus real preferences both under- and over-valuation occurs.CLINICAL SIGNIFICANCEWide and unpredictable variation in valuations for prevention may mean that there are difficult policy questions around what resource should be allocated to dental prevention and how to target this resource.

100 Deals associated with CHX Technologies, Inc.

Login to view more data

100 Translational Medicine associated with CHX Technologies, Inc.

Login to view more data